Pulmonx makes medical devices to treat severe emphysema, a lung disease that makes it hard to breathe. Their main product is the Zephyr Endobronchial Valve, a small device placed inside airways to help patients breathe better without open surgery. The company also sells the Chartis system, which doctors use to test lungs before treatment, and LungTraX, a cloud-based software that analyzes lung scans to help doctors plan treatment for individual patients. Pulmonx sells these products to hospitals and clinics in the United States and around the world.
1D1W1M3M1Y5YMAX
Loading chart...
Chart powered by TradingView Lightweight Charts
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
What each number means, in plain English, with the Wall Street name where the two differ.
A plain-English summary of the company.
How many analysts cover it, and the count behind each rating.